// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Bariatric Surgery is Associated With Reduced Atherosclerotic Cardiovascular Disease Burden in Obese Patients With Type 2 Diabetes: A Propensity-matched Cohort Study

Francesca Watson - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Empagliflozin Reduces the Total Burden of Cardiovascular Events Including Recurrent Events in the EMPA-REG OUTCOME Trial

David H Fitchett - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Transient Ischemic Attack

BI-10773

Burden of Cardiovascular or Fatal Outcomes in People With Type 2 Diabetes and Cardiovascular Risk Factors Treated With Dulaglutide a Post Hoc Analysis From the Rewind Trial

Gilles Dagenais - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

Dulaglutide

Rising Prevalence of Obesity in the Us: National Health and Nutrition Examination Survey (NHANES) 2003-2018

michael palmer - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Obesity

N/A

Short-term Sequalae of Children With Paediatric Inflammatory Multisystem Syndrome Temporarily Associated With Sars-cov-2 Infection (pims-ts) Assessed by Cardiovascular Magnetic Resonance

Ivan Bermejo Altamar - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Left ventricular dysfunction

N/A

Physical Activity in Individuals With the Long Qt Syndrome: Baseline Data From the Lifestyle and Exercise in Long Qt Study (live Lqts)

Rachel J Lampert - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Long QT syndrome

N/A

Cardiac MRI Predictors of Good Long-term Outcomes in Patients With Repaired TOF

Amara Majeed - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

N/A

Impact of VAD Support Duration on Pediatric Heart Transplant Outcomes

Arene Butto - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

An Ischaemia Time of Greater Than 6 Hours is Associated With Deleterious Outcomes in Pediatric Heart Transplantation

Adam Arshad - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Presentation and Outcome of Pediatric Multisystem Inflammatory Syndrome Temporally Associated With Sars-cov-2 Pandemic: An International Survey

Carles Bautista - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Clinical Outcomes for Children With Paediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 (PIMS-TS)

Heechan Kang - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Left ventricular dysfunction

N/A

Clinical Significance of Coronavirus Disease 2019 in Hospitalized Patients With Myocardial Injury

Michael Briscoe - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Myocardial infarction

N/A

Segmental and Global Longitudinal Strain Differences Between Children With Paediatric Inflammatory Multisystem Syndrome Temporally Associated With Sars-cov-2 Pandemic and Kawasaki Disease: Preliminary Data From an Ongoing Study

Enrico Piccinelli - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Kawasaki disease

N/A

Outcomes of the Hybrid Convergent Procedure Compared to Catheter Ablation Stratified by Anti-arrhythmic Drug Usage: Results From Converge Ide, Prospective, Randomized, Multi-center Trial

David De Lurgio - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

N/A

An Open-label, Multicenter Study of Flecainide Acetate Oral Inhalation Solution Shows Acute Conversion of Recent-onset, Symptomatic Atrial Fibrillation to Sinus Rhythm in a Dose- and Concentration-dependent Manner

Harry Crijns - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

Flecainide

Prevalence and Outcomes of Arrhythmia in Tumor Lysis Syndrome: A National Perspective

Rupak Desai - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Tumor lysis syndrome

N/A

Incidence and Risk Factors of Device-related Infection in De Novo Transvenous Implantable Cardiac Defibrillator Medicare Patients

Mikhael F El-Chami - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Multicenter Prospective Prevention of Sudden Death in High Risk Patients Utilizing Enhanced ACC/AHA Risk Model

Ethan J Rowin - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Personalized Computational Modeling Identifies Embolic Stroke of Undetermined Source Patients With Potential Arrhythmic Substrate

Savannah Bifulco - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Arrhythmia

N/A

Characterisation of Recent Trends in Cardiovascular Risk Factors in Younger Patients With Ischaemic Stroke

Aditya Bhat - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Transient Ischemic Attack

N/A

Copyright © 2026. QuantiNova All rights reserved